Galena Biopharma to Present at the World Cancer Immunotherapy Conference
LAKE OSWEGO, Ore., Jan. 24, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will provide a presentation entitled, "Cancer Vaccine Development Strategies" at The World Cancer Immunotherapy Conference. The presentation will take place on Wednesday, January 25, 2012 at 9:40 am PST at the Hilton San Diego Gaslamp Quarter in San Diego, CA.
About Galena Biopharma
Galena Biopharma, Inc. is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com .
The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 firstname.lastname@example.org or Remy Bernarda IR Sense, LLC +1 (503) 400-6995 email@example.com
Source: Galena Biopharma 2012 GlobeNewswire, Inc.